新型固定剂量降压制剂arb-hctz临床应用专家共识最终稿（New fixed dose antihypertensive preparation arb-hctz clinical application expert consensus final draft）.doc

新型固定剂量降压制剂arb-hctz临床应用专家共识最终稿（New fixed dose antihypertensive preparation arb-hctz clinical application expert consensus final draft） Preface: pay attention to the clinical application of fixed dose compound antihypertensive drugs to improve the control rate of hypertension in China . Hypertension has become one of the major diseases in the world. In 2000, the proportion of hypertensive patients in the world accounted for 26% of adults, about 970 million, is expected in 2050 the prevalence of hypertension will increase by 60%, the number of patients about 1 billion 560 million (1). Chinas population aging rapidly, at the same time, with the rapid economic growth, way of life has undergone tremendous changes, such as the increase in the number of overweight and obesity, dyslipidemia increased, accelerate the pace of life, the lack of physical exercise, these have led to the current rapid growth rate of hypertension in china. The latest nationwide hypertension epidemiological survey completed in 2002 showed that the prevalence of hypertension was 18.8%, up from 31% in 1991 and 160 million in the country. Hypertension is the most common and controllable risk factor of cardiovascular and cerebrovascular diseases, and its global prevalence leads to a significant increase in the burden of cardiovascular and cerebrovascular diseases. Moreover, we may have underestimated the burden of cardiovascular disease caused by elevated blood pressure. According to the WHO report, about 11% of the burden of disease in developed countries in 2002 came from hypertension, and more than 50% of coronary heart disease and nearly 75% of strokes were caused by a systolic pressure exceeding the theoretical minimum of 115mmHg (2). In another case involving 52 international large case-control studies, INTERHEART showed that coronary heart disease was nearly 2 times higher in hypertensive patients than in those without hypertension (3). He et al., China 169, The causes of death of 871 adults over